Induction of HPV16 Capsid Protein-Specific Human T Cell Responses by Virus-Like Particles
Michael P. Rudolf(Biognosys (Switzerland)), W. Martin Kast(University of Southern California), Diane DaSilva, John T. Schiller(National Cancer Institute), John D. Nieland(Aalborg University), Martin Müller(Klinikum Region Hannover), Markwin P. Velders(Loyola University Chicago), Heather L. Greenstone(National Institutes of Health)
Cited by 46
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.
|The EMBO Journal|1989|930
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells
|Nature Medicine|2002|549